1 / 12

APIs India & China

APIs India & China. Dr. Brian W Tempest www.briantempest.com March 2009 Bangladesh. Chinese DMFs. Indian DMFs now >50%. Indian DMFs versus All DMFs. DMFs for New Molecules. Indian DMFs - 1. Indian DMFs -2. Indian DMFs -3. Indian DMFs - 4. Indian DMF Niches. In Summary.

hamlin
Download Presentation

APIs India & China

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. APIs India & China Dr. Brian W Tempest www.briantempest.com March 2009 Bangladesh

  2. Chinese DMFs

  3. Indian DMFs now >50%

  4. Indian DMFs versus All DMFs

  5. DMFs for New Molecules

  6. Indian DMFs - 1

  7. Indian DMFs -2

  8. Indian DMFs -3

  9. Indian DMFs - 4

  10. Indian DMF Niches

  11. In Summary • 4Q08 DMFs filed with FDA represent 51% of all filings for the first time. Q308 was 43% • China DMFs now represents only 8% • 23 new molecules have seen Indian filings - leading to a total filing from India now of 398 molecules. $3.1b sales • The big cap Indian companies are taking a smaller share in new filings • The number of molecules with more than 5 Indian filings has risen to 82 from 75 in Q308

  12. Thank You

More Related